Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eye Neoplasms | 22 | 2007 | 313 | 2.800 |
Why?
|
Fas Ligand Protein | 9 | 2018 | 217 | 1.820 |
Why?
|
Anterior Chamber | 22 | 2006 | 195 | 1.630 |
Why?
|
Limbus Corneae | 7 | 2023 | 142 | 1.290 |
Why?
|
Epithelium, Corneal | 6 | 2022 | 241 | 1.170 |
Why?
|
Uveal Neoplasms | 13 | 2022 | 310 | 1.160 |
Why?
|
T-Lymphocytes, Cytotoxic | 23 | 2009 | 1820 | 1.080 |
Why?
|
Glaucoma | 4 | 2023 | 1152 | 0.770 |
Why?
|
Keratitis | 3 | 2023 | 268 | 0.750 |
Why?
|
Eye | 8 | 2020 | 728 | 0.730 |
Why?
|
Melanoma | 23 | 2022 | 5462 | 0.730 |
Why?
|
Optic Nerve Diseases | 1 | 2023 | 327 | 0.720 |
Why?
|
Cancer Vaccines | 9 | 2009 | 1021 | 0.660 |
Why?
|
Corneal Transplantation | 12 | 2009 | 368 | 0.660 |
Why?
|
Mast-Cell Sarcoma | 9 | 2007 | 47 | 0.600 |
Why?
|
Mastocytoma | 2 | 2006 | 5 | 0.570 |
Why?
|
Tumor Escape | 4 | 2007 | 349 | 0.550 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 8 | 2007 | 1038 | 0.550 |
Why?
|
Debridement | 1 | 2018 | 492 | 0.540 |
Why?
|
Retinal Ganglion Cells | 4 | 2023 | 771 | 0.540 |
Why?
|
Neoplasm Transplantation | 20 | 2018 | 2085 | 0.540 |
Why?
|
Mice, Inbred DBA | 14 | 2016 | 642 | 0.540 |
Why?
|
Optic Nerve | 2 | 2023 | 548 | 0.530 |
Why?
|
Stem Cells | 12 | 2023 | 3563 | 0.530 |
Why?
|
Hypersensitivity, Delayed | 14 | 2006 | 485 | 0.520 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1060 | 0.490 |
Why?
|
Lymphocyte Activation | 21 | 2011 | 5519 | 0.470 |
Why?
|
Retinal Pigment Epithelium | 2 | 2015 | 302 | 0.460 |
Why?
|
Disease Models, Animal | 8 | 2023 | 18006 | 0.450 |
Why?
|
Graft Rejection | 16 | 2009 | 4393 | 0.440 |
Why?
|
Retinal Neurons | 1 | 2013 | 65 | 0.440 |
Why?
|
Guanylate Cyclase | 1 | 2013 | 201 | 0.420 |
Why?
|
Leukemia L5178 | 3 | 2007 | 14 | 0.410 |
Why?
|
Minor Histocompatibility Loci | 2 | 2007 | 18 | 0.400 |
Why?
|
Conjunctival Neoplasms | 3 | 2018 | 79 | 0.390 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2014 | 559 | 0.380 |
Why?
|
Mice | 63 | 2023 | 81045 | 0.380 |
Why?
|
Corneal Neovascularization | 4 | 2023 | 188 | 0.380 |
Why?
|
Interleukin-12 | 5 | 2006 | 579 | 0.360 |
Why?
|
Multiple Sclerosis | 1 | 2023 | 3076 | 0.330 |
Why?
|
Animals | 74 | 2023 | 168561 | 0.320 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 867 | 0.320 |
Why?
|
Glaucoma, Open-Angle | 2 | 2013 | 711 | 0.320 |
Why?
|
Inflammasomes | 1 | 2013 | 493 | 0.310 |
Why?
|
Wound Healing | 3 | 2018 | 2781 | 0.310 |
Why?
|
Lysosomes | 1 | 2013 | 893 | 0.310 |
Why?
|
Tumor Cells, Cultured | 20 | 2015 | 6313 | 0.300 |
Why?
|
Blindness | 2 | 2023 | 615 | 0.280 |
Why?
|
Neoplasms, Experimental | 5 | 2015 | 1274 | 0.280 |
Why?
|
Antigens, Neoplasm | 7 | 2006 | 1983 | 0.280 |
Why?
|
CD4-Positive T-Lymphocytes | 8 | 2008 | 4379 | 0.280 |
Why?
|
Immune Tolerance | 7 | 2003 | 2257 | 0.270 |
Why?
|
Fluorescent Antibody Technique, Indirect | 4 | 2018 | 428 | 0.270 |
Why?
|
Cell Membrane | 3 | 2011 | 3744 | 0.270 |
Why?
|
Corneal Diseases | 3 | 2021 | 615 | 0.260 |
Why?
|
Immunotherapy | 6 | 2011 | 4414 | 0.260 |
Why?
|
Regeneration | 1 | 2014 | 1485 | 0.260 |
Why?
|
Macular Degeneration | 1 | 2013 | 980 | 0.260 |
Why?
|
Epigenesis, Genetic | 3 | 2023 | 3639 | 0.250 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 1999 | 880 | 0.250 |
Why?
|
Cytotoxicity, Immunologic | 7 | 2006 | 1368 | 0.250 |
Why?
|
Minor Histocompatibility Antigens | 5 | 1999 | 298 | 0.240 |
Why?
|
Transfection | 8 | 2014 | 5892 | 0.240 |
Why?
|
Histocompatibility Antigens Class II | 7 | 2009 | 1470 | 0.240 |
Why?
|
Microglia | 3 | 2019 | 1261 | 0.240 |
Why?
|
Membrane Glycoproteins | 3 | 2005 | 3769 | 0.240 |
Why?
|
Choroid Neoplasms | 2 | 1998 | 175 | 0.240 |
Why?
|
Immunity, Innate | 3 | 2007 | 2956 | 0.240 |
Why?
|
Dioxygenases | 2 | 2023 | 316 | 0.230 |
Why?
|
Mice, Inbred BALB C | 24 | 2015 | 6382 | 0.230 |
Why?
|
Intraocular Pressure | 2 | 2023 | 1274 | 0.230 |
Why?
|
Corneal Stroma | 3 | 2018 | 170 | 0.220 |
Why?
|
Cell Line, Tumor | 17 | 2020 | 16665 | 0.220 |
Why?
|
Plasmids | 2 | 2018 | 2305 | 0.220 |
Why?
|
Ribosomal Protein S6 | 1 | 2022 | 70 | 0.220 |
Why?
|
Ribonucleotides | 2 | 2014 | 117 | 0.210 |
Why?
|
Aminoimidazole Carboxamide | 2 | 2014 | 88 | 0.210 |
Why?
|
Histocompatibility Antigens Class I | 6 | 2018 | 1366 | 0.200 |
Why?
|
GTP Phosphohydrolases | 2 | 2015 | 508 | 0.200 |
Why?
|
Injections | 5 | 2011 | 840 | 0.190 |
Why?
|
Mice, SCID | 7 | 2015 | 2715 | 0.190 |
Why?
|
Neoplasm Metastasis | 3 | 2022 | 4839 | 0.190 |
Why?
|
Cell Death | 4 | 2018 | 1695 | 0.190 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2006 | 4438 | 0.190 |
Why?
|
Eye Injuries | 1 | 2023 | 245 | 0.180 |
Why?
|
Retinoblastoma Protein | 2 | 2015 | 701 | 0.180 |
Why?
|
Mice, Inbred C57BL | 20 | 2020 | 21821 | 0.180 |
Why?
|
Retina | 4 | 2023 | 2611 | 0.180 |
Why?
|
Major Histocompatibility Complex | 6 | 1999 | 935 | 0.180 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2022 | 2107 | 0.170 |
Why?
|
Aging | 3 | 2023 | 8626 | 0.170 |
Why?
|
Carrier Proteins | 1 | 2013 | 5019 | 0.170 |
Why?
|
Cytotoxicity Tests, Immunologic | 5 | 2007 | 329 | 0.170 |
Why?
|
Stem Cell Transplantation | 3 | 2018 | 1618 | 0.170 |
Why?
|
Adenoviridae | 2 | 2018 | 1096 | 0.170 |
Why?
|
Immunity, Cellular | 8 | 2006 | 1606 | 0.170 |
Why?
|
Genetic Vectors | 6 | 2020 | 3420 | 0.160 |
Why?
|
Mice, Mutant Strains | 2 | 2013 | 1866 | 0.160 |
Why?
|
Endophthalmitis | 2 | 2013 | 263 | 0.160 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2018 | 132 | 0.150 |
Why?
|
Staphylococcal Infections | 3 | 2013 | 1398 | 0.150 |
Why?
|
HLA-DR Antigens | 4 | 2009 | 644 | 0.150 |
Why?
|
Vision, Ocular | 1 | 2020 | 463 | 0.150 |
Why?
|
T-Lymphocytes | 9 | 2011 | 10163 | 0.150 |
Why?
|
Keratitis, Herpetic | 1 | 1997 | 81 | 0.150 |
Why?
|
Isoantigens | 7 | 1997 | 567 | 0.150 |
Why?
|
Sarcoma, Experimental | 1 | 1996 | 128 | 0.140 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2018 | 204 | 0.140 |
Why?
|
GTP-Binding Protein alpha Subunits | 2 | 2014 | 100 | 0.140 |
Why?
|
Sialomucins | 1 | 2016 | 15 | 0.140 |
Why?
|
Vision Disorders | 1 | 2023 | 1057 | 0.140 |
Why?
|
Lymphocyte Culture Test, Mixed | 3 | 2006 | 517 | 0.140 |
Why?
|
H-2 Antigens | 3 | 2006 | 365 | 0.140 |
Why?
|
Green Fluorescent Proteins | 3 | 2018 | 2088 | 0.140 |
Why?
|
DNA Methylation | 4 | 2023 | 4282 | 0.130 |
Why?
|
Uveitis | 1 | 2019 | 375 | 0.130 |
Why?
|
Neoplasm Proteins | 3 | 2003 | 3691 | 0.130 |
Why?
|
Blotting, Western | 4 | 2018 | 5180 | 0.130 |
Why?
|
Immunocompetence | 1 | 2015 | 137 | 0.130 |
Why?
|
Retinoblastoma | 3 | 2012 | 318 | 0.130 |
Why?
|
Blood | 1 | 1997 | 598 | 0.130 |
Why?
|
Nerve Regeneration | 1 | 2020 | 791 | 0.130 |
Why?
|
Photoreceptor Cells | 1 | 2015 | 244 | 0.120 |
Why?
|
rho GTP-Binding Proteins | 2 | 2014 | 293 | 0.120 |
Why?
|
Phosphotransferases (Phosphate Group Acceptor) | 1 | 2014 | 17 | 0.120 |
Why?
|
Melanocytes | 2 | 2016 | 515 | 0.120 |
Why?
|
Lymphangiogenesis | 1 | 2015 | 172 | 0.120 |
Why?
|
Retinal Detachment | 1 | 2018 | 411 | 0.120 |
Why?
|
Liver Neoplasms | 4 | 2022 | 4249 | 0.120 |
Why?
|
Immunity | 4 | 2000 | 1011 | 0.110 |
Why?
|
RNA, Viral | 1 | 2021 | 2899 | 0.110 |
Why?
|
Retinal Diseases | 1 | 2019 | 683 | 0.110 |
Why?
|
Inflammation | 5 | 2023 | 10578 | 0.110 |
Why?
|
RNA, Neoplasm | 2 | 2014 | 768 | 0.110 |
Why?
|
Optic Disk Drusen | 1 | 2013 | 35 | 0.110 |
Why?
|
Flow Cytometry | 6 | 2018 | 5975 | 0.110 |
Why?
|
Phenylenediamines | 1 | 2013 | 90 | 0.110 |
Why?
|
Ophthalmoscopy | 1 | 2013 | 176 | 0.110 |
Why?
|
Mice, Inbred Strains | 9 | 1998 | 1827 | 0.100 |
Why?
|
Antigens | 2 | 1997 | 1462 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2023 | 4414 | 0.100 |
Why?
|
Caspase 1 | 1 | 2013 | 223 | 0.100 |
Why?
|
Cell Differentiation | 7 | 2023 | 11470 | 0.100 |
Why?
|
Macrophages | 3 | 2023 | 5655 | 0.100 |
Why?
|
Mice, Knockout | 5 | 2014 | 14554 | 0.100 |
Why?
|
Transcription Factor AP-1 | 1 | 2012 | 317 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2018 | 8425 | 0.100 |
Why?
|
Humans | 52 | 2023 | 742088 | 0.100 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 2211 | 0.100 |
Why?
|
Enzyme Activation | 2 | 2014 | 3701 | 0.100 |
Why?
|
Female | 36 | 2020 | 379592 | 0.090 |
Why?
|
DNA, Neoplasm | 2 | 2015 | 1758 | 0.090 |
Why?
|
Cytoprotection | 1 | 2011 | 210 | 0.090 |
Why?
|
Solubility | 2 | 2011 | 1083 | 0.090 |
Why?
|
Cornea | 5 | 2023 | 1497 | 0.090 |
Why?
|
Apoptosis | 6 | 2016 | 9715 | 0.090 |
Why?
|
Interferon-gamma | 5 | 2009 | 3199 | 0.090 |
Why?
|
Adenylate Kinase | 1 | 2010 | 100 | 0.090 |
Why?
|
Cell Proliferation | 6 | 2015 | 10472 | 0.090 |
Why?
|
Nuclear Proteins | 3 | 2014 | 5851 | 0.090 |
Why?
|
Immunization | 3 | 2006 | 1255 | 0.090 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 1992 | 986 | 0.090 |
Why?
|
Aqueous Humor | 3 | 2003 | 161 | 0.090 |
Why?
|
Corneal Ulcer | 1 | 2011 | 169 | 0.090 |
Why?
|
Antigens, Differentiation | 2 | 2005 | 926 | 0.090 |
Why?
|
alpha-MSH | 1 | 2009 | 68 | 0.090 |
Why?
|
Cell Adhesion | 1 | 2016 | 3139 | 0.080 |
Why?
|
Azacitidine | 2 | 2003 | 347 | 0.080 |
Why?
|
RNA, Small Interfering | 3 | 2016 | 3504 | 0.080 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2012 | 581 | 0.080 |
Why?
|
Antigen-Presenting Cells | 3 | 2007 | 969 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 2 | 2014 | 2842 | 0.080 |
Why?
|
Injections, Subcutaneous | 2 | 2006 | 664 | 0.080 |
Why?
|
alpha-Crystallin B Chain | 1 | 2008 | 23 | 0.080 |
Why?
|
Keratitis, Dendritic | 1 | 1987 | 35 | 0.080 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2016 | 1155 | 0.080 |
Why?
|
Transplantation, Homologous | 9 | 2009 | 4771 | 0.080 |
Why?
|
Immunohistochemistry | 4 | 2015 | 11363 | 0.080 |
Why?
|
Eye Infections, Bacterial | 1 | 2011 | 235 | 0.080 |
Why?
|
Endothelial Cells | 2 | 2022 | 3455 | 0.080 |
Why?
|
Leukocytes | 1 | 2016 | 2039 | 0.080 |
Why?
|
Melanoma-Specific Antigens | 2 | 1997 | 80 | 0.080 |
Why?
|
Lymphatic Metastasis | 1 | 2015 | 2906 | 0.080 |
Why?
|
Mitosis | 1 | 2012 | 1208 | 0.070 |
Why?
|
Nerve Fibers | 1 | 2011 | 688 | 0.070 |
Why?
|
Immunotherapy, Active | 1 | 2007 | 60 | 0.070 |
Why?
|
Mammals | 2 | 2023 | 1135 | 0.070 |
Why?
|
Interleukin-1beta | 1 | 2013 | 972 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2130 | 0.070 |
Why?
|
HEK293 Cells | 2 | 2014 | 4200 | 0.070 |
Why?
|
Staphylococcus aureus | 3 | 2013 | 1449 | 0.070 |
Why?
|
Leukemia L1210 | 1 | 2006 | 45 | 0.070 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2007 | 318 | 0.070 |
Why?
|
Retinal Degeneration | 1 | 2011 | 414 | 0.070 |
Why?
|
Ligands | 2 | 2005 | 3293 | 0.070 |
Why?
|
Cell Survival | 6 | 2020 | 5872 | 0.070 |
Why?
|
Transcription Factors | 3 | 2014 | 12164 | 0.060 |
Why?
|
Interleukin-2 | 6 | 2009 | 1887 | 0.060 |
Why?
|
Trans-Activators | 2 | 2006 | 2924 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 1221 | 0.060 |
Why?
|
Graft Survival | 6 | 2009 | 3733 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2015 | 2028 | 0.060 |
Why?
|
Neutrophils | 3 | 2016 | 3711 | 0.060 |
Why?
|
Immunophenotyping | 3 | 1998 | 1866 | 0.060 |
Why?
|
Gene Knockdown Techniques | 3 | 2015 | 1655 | 0.060 |
Why?
|
RNA, Messenger | 4 | 2018 | 13029 | 0.060 |
Why?
|
Killer Cells, Natural | 2 | 2007 | 2133 | 0.060 |
Why?
|
Gene Expression Regulation | 3 | 2018 | 12071 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6365 | 0.060 |
Why?
|
NF-kappa B | 1 | 2013 | 2500 | 0.060 |
Why?
|
Simplexvirus | 1 | 1987 | 802 | 0.060 |
Why?
|
Gene Expression | 5 | 2012 | 7790 | 0.060 |
Why?
|
Skin Neoplasms | 3 | 2014 | 5662 | 0.060 |
Why?
|
Dependovirus | 2 | 2020 | 706 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2003 | 99 | 0.060 |
Why?
|
Genes, Reporter | 1 | 2007 | 1547 | 0.060 |
Why?
|
Retinal Neoplasms | 2 | 2012 | 144 | 0.060 |
Why?
|
Antigens, Viral | 1 | 1987 | 1034 | 0.060 |
Why?
|
Genes, MHC Class II | 1 | 2004 | 458 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 3 | 2006 | 1837 | 0.060 |
Why?
|
Myeloid Cells | 1 | 2008 | 804 | 0.060 |
Why?
|
Mice, Inbred C3H | 2 | 2002 | 964 | 0.050 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2014 | 140 | 0.050 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 18112 | 0.050 |
Why?
|
Chemokine CXCL2 | 1 | 2002 | 111 | 0.050 |
Why?
|
Nucleoproteins | 1 | 2023 | 115 | 0.050 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2002 | 159 | 0.050 |
Why?
|
5-Methylcytosine | 1 | 2023 | 153 | 0.050 |
Why?
|
Microscopy, Confocal | 2 | 2005 | 1969 | 0.050 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2002 | 370 | 0.050 |
Why?
|
Signal Transduction | 4 | 2014 | 23387 | 0.050 |
Why?
|
Down-Regulation | 2 | 2006 | 3001 | 0.050 |
Why?
|
Luminescent Proteins | 1 | 2004 | 853 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2002 | 772 | 0.050 |
Why?
|
Proteoglycans | 1 | 2004 | 834 | 0.050 |
Why?
|
Thromboplastin | 1 | 2002 | 291 | 0.050 |
Why?
|
Cells, Cultured | 4 | 2022 | 19223 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2002 | 2638 | 0.050 |
Why?
|
Tomography, Optical Coherence | 1 | 2013 | 2637 | 0.050 |
Why?
|
Cell Division | 4 | 1999 | 4564 | 0.050 |
Why?
|
Antigens, CD | 1 | 2011 | 4024 | 0.050 |
Why?
|
Endothelial Growth Factors | 2 | 2002 | 694 | 0.050 |
Why?
|
Receptors, Chemokine | 1 | 2023 | 669 | 0.050 |
Why?
|
Immediate-Early Proteins | 1 | 2002 | 453 | 0.040 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2020 | 223 | 0.040 |
Why?
|
Lymphokines | 2 | 2002 | 949 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 1999 | 175 | 0.040 |
Why?
|
Langerhans Cells | 1 | 2000 | 173 | 0.040 |
Why?
|
Cell Movement | 5 | 2014 | 5212 | 0.040 |
Why?
|
Optic Nerve Injuries | 1 | 2020 | 151 | 0.040 |
Why?
|
Species Specificity | 2 | 2002 | 2479 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 2 | 2023 | 4553 | 0.040 |
Why?
|
History, 20th Century | 1 | 2007 | 2739 | 0.040 |
Why?
|
SOXB1 Transcription Factors | 1 | 2020 | 284 | 0.040 |
Why?
|
Karyotyping | 1 | 2001 | 1243 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2022 | 3678 | 0.040 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 110 | 0.040 |
Why?
|
Receptors, KIR | 1 | 1999 | 113 | 0.040 |
Why?
|
Protein Binding | 1 | 2011 | 9387 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2002 | 1262 | 0.040 |
Why?
|
Transforming Growth Factor beta | 4 | 1999 | 2006 | 0.040 |
Why?
|
Transduction, Genetic | 3 | 2007 | 913 | 0.040 |
Why?
|
Mice, Transgenic | 4 | 2018 | 9735 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2000 | 430 | 0.040 |
Why?
|
Organic Chemicals | 1 | 2019 | 211 | 0.040 |
Why?
|
Th1 Cells | 2 | 2007 | 1056 | 0.040 |
Why?
|
Genes, MHC Class I | 1 | 1999 | 258 | 0.040 |
Why?
|
Chemokines | 1 | 2002 | 954 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 4751 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7873 | 0.040 |
Why?
|
Bovine papillomavirus 1 | 1 | 1997 | 74 | 0.040 |
Why?
|
Gene Silencing | 1 | 2004 | 1538 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2020 | 504 | 0.040 |
Why?
|
Peritoneal Cavity | 1 | 1997 | 148 | 0.040 |
Why?
|
Virus Internalization | 1 | 2021 | 501 | 0.040 |
Why?
|
Lymphocyte Depletion | 3 | 2001 | 608 | 0.040 |
Why?
|
Histocompatibility Testing | 2 | 1996 | 742 | 0.040 |
Why?
|
Rabbits | 2 | 2002 | 4886 | 0.040 |
Why?
|
Antineoplastic Agents | 3 | 2014 | 13655 | 0.040 |
Why?
|
Serum Albumin, Bovine | 1 | 1997 | 324 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2021 | 2335 | 0.040 |
Why?
|
Antigens, Surface | 2 | 1991 | 1663 | 0.040 |
Why?
|
DNA-Binding Proteins | 3 | 2023 | 9639 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2004 | 1989 | 0.030 |
Why?
|
Male | 15 | 2019 | 349538 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 1994 | 2986 | 0.030 |
Why?
|
Mycobacterium | 1 | 1997 | 249 | 0.030 |
Why?
|
Allergy and Immunology | 1 | 1997 | 169 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 3 | 1993 | 1255 | 0.030 |
Why?
|
Cerebrospinal Fluid | 1 | 1998 | 534 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2003 | 2513 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2002 | 1675 | 0.030 |
Why?
|
Acute Disease | 4 | 2016 | 7141 | 0.030 |
Why?
|
Mitogens | 2 | 2012 | 232 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6171 | 0.030 |
Why?
|
Azo Compounds | 1 | 2015 | 113 | 0.030 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2016 | 378 | 0.030 |
Why?
|
Carboplatin | 1 | 1997 | 799 | 0.030 |
Why?
|
Mutation | 3 | 2015 | 29717 | 0.030 |
Why?
|
Cytokines | 2 | 1999 | 7317 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2001 | 1811 | 0.030 |
Why?
|
Interleukin-4 | 3 | 1993 | 1146 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 1997 | 401 | 0.030 |
Why?
|
Viral Proteins | 1 | 2021 | 1899 | 0.030 |
Why?
|
DNA, Complementary | 1 | 1997 | 2049 | 0.030 |
Why?
|
Neoplasms | 3 | 2012 | 21596 | 0.030 |
Why?
|
Clone Cells | 1 | 1997 | 1692 | 0.030 |
Why?
|
Monocytes | 1 | 2023 | 2593 | 0.030 |
Why?
|
Cell Cycle | 2 | 2014 | 2964 | 0.030 |
Why?
|
Cell Separation | 1 | 2019 | 1749 | 0.030 |
Why?
|
Tissue Donors | 2 | 2019 | 2205 | 0.030 |
Why?
|
Decidua | 1 | 1994 | 86 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 400 | 0.030 |
Why?
|
Interleukin-10 | 1 | 1999 | 1200 | 0.030 |
Why?
|
Autoantigens | 1 | 1997 | 891 | 0.030 |
Why?
|
Antigen Presentation | 1 | 1999 | 1284 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 5867 | 0.030 |
Why?
|
Organ Specificity | 1 | 1997 | 2003 | 0.030 |
Why?
|
Axons | 1 | 2020 | 1681 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 1999 | 1423 | 0.030 |
Why?
|
Trophoblasts | 1 | 1994 | 215 | 0.030 |
Why?
|
Th2 Cells | 1 | 1997 | 1049 | 0.030 |
Why?
|
Founder Effect | 1 | 2012 | 190 | 0.030 |
Why?
|
Retroviridae | 2 | 2006 | 914 | 0.030 |
Why?
|
Ovalbumin | 3 | 1999 | 719 | 0.030 |
Why?
|
Herpesvirus 1, Human | 1 | 1997 | 742 | 0.030 |
Why?
|
Eye Enucleation | 1 | 1991 | 128 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 1997 | 4322 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2023 | 2749 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2002 | 3502 | 0.030 |
Why?
|
Spleen | 3 | 1998 | 2359 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 677 | 0.020 |
Why?
|
Central Nervous System | 1 | 1998 | 1354 | 0.020 |
Why?
|
Eye Proteins | 1 | 1994 | 644 | 0.020 |
Why?
|
Interleukins | 2 | 1993 | 791 | 0.020 |
Why?
|
DNA Mutational Analysis | 2 | 2015 | 4187 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1670 | 0.020 |
Why?
|
Testis | 1 | 1994 | 800 | 0.020 |
Why?
|
Ophthalmology | 1 | 2016 | 506 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3618 | 0.020 |
Why?
|
Peroxidase | 1 | 2013 | 610 | 0.020 |
Why?
|
Immunoenzyme Techniques | 2 | 2003 | 1799 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1875 | 0.020 |
Why?
|
Secretory Pathway | 1 | 2009 | 51 | 0.020 |
Why?
|
Autoimmunity | 1 | 1997 | 1348 | 0.020 |
Why?
|
Clozapine | 1 | 2012 | 498 | 0.020 |
Why?
|
Thrombospondin 1 | 1 | 2011 | 250 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2007 | 20774 | 0.020 |
Why?
|
RNA, Bacterial | 1 | 2011 | 391 | 0.020 |
Why?
|
Phenotype | 1 | 2006 | 16331 | 0.020 |
Why?
|
Toll-Like Receptor 2 | 1 | 2011 | 354 | 0.020 |
Why?
|
Mice, Inbred A | 2 | 2000 | 248 | 0.020 |
Why?
|
Tight Junctions | 1 | 2011 | 310 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2012 | 1284 | 0.020 |
Why?
|
Growth Inhibitors | 1 | 1989 | 385 | 0.020 |
Why?
|
Mucins | 1 | 2011 | 564 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2022 | 5163 | 0.020 |
Why?
|
Lymphocytes | 2 | 1993 | 2614 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2011 | 947 | 0.020 |
Why?
|
Lymphocyte Subsets | 1 | 2008 | 315 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1996 | 6608 | 0.020 |
Why?
|
Fetus | 1 | 1994 | 1879 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 1997 | 3164 | 0.020 |
Why?
|
Mice, Nude | 1 | 2012 | 3689 | 0.020 |
Why?
|
Caspase 3 | 1 | 2008 | 759 | 0.020 |
Why?
|
Disease Progression | 2 | 2003 | 13256 | 0.020 |
Why?
|
Skin | 2 | 2016 | 4353 | 0.020 |
Why?
|
Cross Reactions | 1 | 2007 | 841 | 0.020 |
Why?
|
Drosophila | 1 | 2012 | 1484 | 0.020 |
Why?
|
Uvea | 1 | 2004 | 31 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2008 | 627 | 0.020 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2004 | 68 | 0.020 |
Why?
|
Endocytosis | 1 | 2009 | 983 | 0.020 |
Why?
|
Pyrazoles | 1 | 2015 | 1970 | 0.020 |
Why?
|
Societies, Medical | 1 | 2016 | 3740 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 1997 | 4664 | 0.010 |
Why?
|
Tissue Inhibitor of Metalloproteinase-3 | 1 | 2003 | 35 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2890 | 0.010 |
Why?
|
Tetanus Toxoid | 1 | 2004 | 193 | 0.010 |
Why?
|
Neuropeptides | 1 | 2009 | 942 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2008 | 13019 | 0.010 |
Why?
|
Retinal Pigments | 1 | 2003 | 83 | 0.010 |
Why?
|
Protein Transport | 1 | 2009 | 1988 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 2012 | 1699 | 0.010 |
Why?
|
STAT1 Transcription Factor | 1 | 2004 | 320 | 0.010 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2002 | 37 | 0.010 |
Why?
|
Zebrafish | 1 | 2014 | 2990 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 1213 | 0.010 |
Why?
|
DNA Modification Methylases | 1 | 2003 | 206 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3444 | 0.010 |
Why?
|
Extracellular Space | 1 | 2004 | 594 | 0.010 |
Why?
|
DNA Probes | 1 | 2003 | 560 | 0.010 |
Why?
|
Cytogenetics | 1 | 2002 | 203 | 0.010 |
Why?
|
Iris | 1 | 2003 | 239 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2018 | 62966 | 0.010 |
Why?
|
Cell Line | 2 | 1998 | 15994 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9144 | 0.010 |
Why?
|
Neovascularization, Physiologic | 2 | 2000 | 1350 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1987 | 1780 | 0.010 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2002 | 657 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2000 | 335 | 0.010 |
Why?
|
Aged | 4 | 2019 | 162944 | 0.010 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2001 | 380 | 0.010 |
Why?
|
Neovascularization, Pathologic | 2 | 2002 | 2633 | 0.010 |
Why?
|
Superantigens | 1 | 1999 | 129 | 0.010 |
Why?
|
Ascitic Fluid | 1 | 1999 | 192 | 0.010 |
Why?
|
Brain | 2 | 1998 | 26343 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2001 | 1374 | 0.010 |
Why?
|
Middle Aged | 4 | 2019 | 213127 | 0.010 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2001 | 462 | 0.010 |
Why?
|
Phosphorylation | 1 | 2010 | 8436 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4211 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5522 | 0.010 |
Why?
|
HeLa Cells | 1 | 2004 | 3127 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 2001 | 515 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2010 | 2866 | 0.010 |
Why?
|
Lymph Nodes | 1 | 1989 | 3465 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2004 | 2699 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53187 | 0.010 |
Why?
|
Adult | 3 | 2023 | 213712 | 0.010 |
Why?
|
Mastocytosis | 1 | 1998 | 160 | 0.010 |
Why?
|
Cell Count | 1 | 2000 | 1831 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2004 | 2440 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2004 | 2968 | 0.010 |
Why?
|
Sutures | 1 | 1997 | 298 | 0.010 |
Why?
|
Retinol-Binding Proteins | 1 | 1994 | 65 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29010 | 0.010 |
Why?
|
Time Factors | 1 | 1996 | 40054 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3920 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57683 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2000 | 1144 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2008 | 3843 | 0.010 |
Why?
|
Exons | 1 | 2000 | 2431 | 0.010 |
Why?
|
Dermatitis, Contact | 1 | 1994 | 129 | 0.010 |
Why?
|
Epitopes | 1 | 2000 | 2569 | 0.010 |
Why?
|
Killer Cells, Lymphokine-Activated | 1 | 1992 | 42 | 0.010 |
Why?
|
Injections, Intralesional | 1 | 1993 | 276 | 0.010 |
Why?
|
Immune System | 1 | 1998 | 804 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 3800 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13814 | 0.010 |
Why?
|
Immunologic Memory | 1 | 1998 | 1348 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17400 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2004 | 4029 | 0.010 |
Why?
|
DNA Replication | 1 | 1997 | 1397 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2004 | 7721 | 0.010 |
Why?
|
Antibodies | 1 | 1998 | 2459 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 1994 | 1059 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 906 | 0.010 |
Why?
|
United States | 1 | 2016 | 69693 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9410 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1997 | 8621 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1997 | 10943 | 0.000 |
Why?
|
Rats | 1 | 1998 | 24265 | 0.000 |
Why?
|
Risk Factors | 1 | 1997 | 72145 | 0.000 |
Why?
|